Skip to main content
Premium Trial:

Request an Annual Quote

Peter Covitz, Matthew Shanahan

Peter Covitz, chief operating officer for the National Cancer Institute’s Center for Bioinformatics, will leave the NCI at the end of February to join MDS Nordion as senior vice president of Innovation. MDS Nordion is a mid-sized nuclear medicine biotech based in Ottawa, Canada.
Covitz worked at the NCICB for six years and played an instrumental role in launching the Cancer Biomedical Informatics Grid project. In a statement posted on the caBIG listserv this week, Kenneth Buetow, director of the NCICB, said that Covitz was “invaluable in guiding many aspects of the initiative — from its core infrastructure to its management, and many components in between.”
Buetow said that Covitz’s caBIG duties will be assigned to “interim point people,” who will be disclosed later.


Authentication software firm BioPassword has appointed Matthew Shanahan as senior vice president of marketing and strategy. Shanahan most recently served as chief marketing officer for Teranode. Prior to that, he was a product manager at Documentum, where he spent 10 years before the company was acquired by EMC. Before that, Shanahan was a manager at Accenture specializing in advanced enterprise architectures for Global 500 companies.

Filed under

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.